{
    "2021-10-29": [
        [
            {
                "time": "",
                "original_text": "安图生物(603658)：3Q21净利润高增长 现金流改善",
                "features": {
                    "keywords": [
                        "安图生物",
                        "3Q21",
                        "净利润",
                        "高增长",
                        "现金流",
                        "改善"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "安图生物(603658)：21Q3业绩符合预期 各项业务恢复较快增长",
                "features": {
                    "keywords": [
                        "安图生物",
                        "21Q3",
                        "业绩",
                        "符合预期",
                        "业务",
                        "恢复",
                        "较快增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}